Intragam-10

What it is used for

Intragam 10 is indicated for replacement IgG therapy in, primary immunodeficiency disease (PID), myeloma and chronic lymphocytic leukaemia with severe secondary hypogammaglobulinemia and recurrent infections, congenital or acquired immune deficiency syndrome with recurrent infections. Intragam 10 is indicated for immunomodulatory therapy in, immune thrombocytopenic purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count, allogeneic bone marrow transplantation, Kawasaki disease, Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), myasthenia gravis (MG) in acute exacerbation (myasthenic crisis) or prior to surgery and/or thymectomy; as maintenance therapy for moderate to severe MG when other treatments have been ineffective or caused intolerable side effects, short-term therapy for severely affected nonparaneoplastic Lambert-Eaton myasthenic syndrome (LEMS) patients, treatment of significant functional impairment in patients who have a verified diagnosis of stiff person syndrome.